series-b
Stage
1
Investors
About
Aqtual develops precision medicine products for chronic disease management and oncology using a novel cell-free DNA platform to create blood tests for disease detection, monitoring, and patient stratification.
Explore Aqtual's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.